Pura Vida Investments, LLC Celldex Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $2.72 Million - $4.95 Million	-132,571 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $22,112 - $31,456	800 Added 0.61%	132,571 $4.52 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $1.94 Million - $3.07 Million	54,486 Added 70.5%	131,771 $5.09 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $803,970 - $1.55 Million	-27,771 Reduced 26.43%	77,285 $4.17 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $1.21 Million - $2.07 Million	-58,559 Reduced 35.79%	105,056 $3.51 Million
Q1 2021 May 12, 2021	BUY	$16.19 - $29.91 $2.65 Million - $4.89 Million	163,615 New	163,615 $3.37 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $2.16 Million - $3.28 Million	-144,200 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $1.02 Million - $1.61 Million	-105,900 Reduced 42.34%	144,200 $2.14 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $402,661 - $3.35 Million	250,100 New	250,100 $3.25 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.1B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.